Asia Pacific Fill-finish Pharmaceutical Contract Manufacturing Market Size & Outlook
Related Markets
Asia Pacific fill-finish pharmaceutical contract manufacturing market highlights
- The Asia Pacific fill-finish pharmaceutical contract manufacturing market generated a revenue of USD 5,066.9 million in 2024.
- The market is expected to grow at a CAGR of 9.6% from 2025 to 2030.
- In terms of segment, cartridges was the largest revenue generating segment in 2024.
- Vials is the most lucrative segment segment registering the fastest growth during the forecast period.
- Country-wise, China is expected to register the highest CAGR from 2025 to 2030.
Asia Pacific data book summary
| Market revenue in 2024 | USD 5,066.9 million |
| Market revenue in 2030 | USD 8,777.6 million |
| Growth rate | 9.6% (CAGR from 2025 to 2030) |
| Largest segment | Cartridges |
| Fastest growing segment | Vials |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Vials, Prefilled Syringes, Cartridges |
| Key market players worldwide | Boehringer Ingelheim, Catalent Inc, Baxter International Inc, Eurofins Scientific SE, Recipharm, Fresenius SE & Co KGaA, Novartis AG ADR, Recro Pharma, Symbiosis Pharmaceutical Services, MabPlex International |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 28.2% of the global fill-finish pharmaceutical contract manufacturing market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 8,777.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Fill-finish Pharmaceutical Contract Manufacturing Market Scope
Fill-finish Pharmaceutical Contract Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| MabPlex International | View profile | 501-1000 | Fremont, California, United States, North America | http://www.mabplex.com |
| Symbiosis Pharmaceutical Services | View profile | 101-250 | Boston, Massachusetts, United States, North America | http://www.symbiosis-pharma.com |
| Recro Pharma | View profile | 251-500 | Malvern, Pennsylvania, United States, North America | http://recropharma.com |
| Recipharm | View profile | 1001-5000 | Jordbro, Stockholms Lan, Sweden, Europe | http://www.recipharm.com |
| Catalent Inc | View profile | 17219 | 14 Schoolhouse Road, Somerset, NJ, United States, 08873 | https://www.catalent.com |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | https://www.boehringer-ingelheim.com/ |
| Eurofins Scientific SE | View profile | 61798 | 23 Val Fleuri, Luxembourg, Luxembourg, L-1526 | https://www.eurofins.com |
| Fresenius SE & Co KGaA | View profile | 193865 | Else-Kroener-Strasse 1, Bad Homburg, HE, Germany, 61352 | https://www.fresenius.com |
| Baxter International Inc | View profile | 60000 | One Baxter Parkway, Deerfield, IL, United States, 60015 | https://www.baxter.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
Asia Pacific fill-finish pharmaceutical contract manufacturing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to fill-finish pharmaceutical contract manufacturing market will help companies and investors design strategic landscapes.
Cartridges was the largest segment with a revenue share of 26.44% in 2024. Horizon Databook has segmented the Asia Pacific fill-finish pharmaceutical contract manufacturing market based on vials, prefilled syringes, cartridges covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific accounted for a revenue share of over 35.3% in 2022 in the fill-finish pharmaceutical contract manufacturing market. The market is driven by key factors, such as growing demand for pharmaceutical products, increasing outsourcing of pharmaceutical production, favorable government policies, and technological advancements.
For instance, in August 2021, Lonza added to the capacity at its biologics manufacturing facility in Guangzhou, China, by installing a new fill-finish line. Wages and material costs are lower in China and India, which drives the market for fill-finish pharmaceutical contract manufacturing.
The rapid expansion of the pharmaceutical industry is likely to be a major factor driving the demand for fill-finish manufacturing in the region. However, with increasing demand for products amid the COVID-19 pandemic, biopharmaceutical and pharmaceutical companies in countries such as India & China, which are the largest exporters to western companies, have increased their production of APIs.
Reasons to subscribe to Asia Pacific fill-finish pharmaceutical contract manufacturing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific fill-finish pharmaceutical contract manufacturing market databook
-
Our clientele includes a mix of fill-finish pharmaceutical contract manufacturing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific fill-finish pharmaceutical contract manufacturing market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific fill-finish pharmaceutical contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific fill-finish pharmaceutical contract manufacturing market size, by country, 2018-2030 (US$M)
Asia Pacific Fill-finish Pharmaceutical Contract Manufacturing Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
